SPC18 Expression Is an Independent Prognostic Indicator of Patients with Esophageal Squamous Cell Carcinoma
Conclusion: Specific inhibitors of SPC18 may be promising anticancer drugs for patients with ESCC.Pathobiology
Source: Pathobiology - Category: Pathology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Genetics | Pathology | Skin Cancer | Squamous Cell Carcinoma | Study